TY  - JOUR
AU  - Bermejo, Javier
AU  - González-Mansilla, Ana
AU  - Mombiela, Teresa
AU  - Fernández, Ana I
AU  - Martínez-Legazpi, Pablo
AU  - Yotti, Raquel
AU  - García-Orta, Rocío
AU  - Sánchez-Fernández, Pedro L
AU  - Castaño, Mario
AU  - Segovia-Cubero, Javier
AU  - Escribano-Subias, Pilar
AU  - Alberto San Román, J
AU  - Borrás, Xavier
AU  - Alonso-Gómez, Angel
AU  - Botas, Javier
AU  - Crespo-Leiro, María G
AU  - Velasco, Sonia
AU  - Bayés-Genís, Antoni
AU  - López, Amador
AU  - Muñoz-Aguilera, Roberto
AU  - Jiménez-Navarro, Manuel
AU  - González-Juanatey, José R
AU  - Evangelista, Arturo
AU  - Elízaga, Jaime
AU  - Martín-Moreiras, Javier
AU  - González-Santos, José M
AU  - Moreno-Escobar, Eduardo
AU  - Fernández-Avilés, Francisco
AU  - SIOVAC (“Sildenafil for Improving Outcomes after VAlvular Correction”) Investigators
PY  - 2021
DO  - 10.1161/JAHA.120.019949
UR  - http://hdl.handle.net/10668/16919
T2  - Journal of the American Heart Association
AB  - Background The determinants and consequences of pulmonary hypertension after successfully corrected valvular heart disease remain poorly understood. We aim to clarify the hemodynamic bases and risk factors for mortality in patients with this...
LA  - en
KW  - heart failure
KW  - pulmonary hypertension
KW  - valvular heart disease
KW  - Diabetes Mellitus
KW  - Double-Blind Method
KW  - Female
KW  - Heart Valve Diseases
KW  - Heart Valve Prosthesis Implantation
KW  - Heart Valves
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - Long Term Adverse Effects
KW  - Male
KW  - Middle Aged
KW  - Organ Size
KW  - Phosphodiesterase 5 Inhibitors
KW  - Postoperative Complications
KW  - Pulmonary Wedge Pressure
KW  - Risk Factors
KW  - Sildenafil Citrate
KW  - Vascular Resistance
TI  - Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival.
TY  - research article
VL  - 10
ER  -